Literature DB >> 7285452

The spine and surgical treatment in osteogenesis imperfecta.

D R Benson, D C Newman.   

Abstract

In the osteogenesis imperfecta patient, spinal deformity should be expected, particularly in the severely affected nonambulator with chest deformity. Curves develop early (age five to six) and generally progress rapidly. Early bracing, although somewhat effective, may well compress the soft osteoporotic rib cage without controlling the spinal curvature. The pulmonary compromise created by the scoliosis is compounded by the chest cage deformity secondary to bracing. In the patient with severe disease (thin bones and numerous fractures), posterior correction and fusion, with or without Harrington instrumentation, is the preferred approach. This should be done early as the osteoporotic bone does not tolerate the hook forces well; the correction is correspondingly limited. The use of methylmethacrylate bone cement around the hook provides redistribution of forces and more stable fixation. In the patient with mild disease (thick bones and few fractures) treatment should be similar to that of patients with idiopathic scoliosis. The chest cage should be carefully observed to avoid deformity from placement of the lateral or posterior pad.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7285452

Source DB:  PubMed          Journal:  Clin Orthop Relat Res        ISSN: 0009-921X            Impact factor:   4.176


  9 in total

1.  Type V osteogenesis imperfecta undergoing surgical correction for scoliosis.

Authors:  Morgan Jones; Lee Breakwell; Ashley Cole; Paul Arundel; Nick Bishop
Journal:  Eur Spine J       Date:  2018-02-19       Impact factor: 3.134

Review 2.  The genetic implication of scoliosis in osteogenesis imperfecta: a review.

Authors:  Gang Liu; Jia Chen; Yangzhong Zhou; Yuzhi Zuo; Sen Liu; Weisheng Chen; Zhihong Wu; Nan Wu
Journal:  J Spine Surg       Date:  2017-12

3.  The sagittal balance of the spine in children and adolescents with osteogenesis imperfecta.

Authors:  Karimane Abelin; Raphaël Vialle; Thibault Lenoir; Camille Thévenin-Lemoine; Jean-Paul Damsin; Véronique Forin
Journal:  Eur Spine J       Date:  2008-09-27       Impact factor: 3.134

4.  Rare causes of scoliosis and spine deformity: experience and particular features.

Authors:  Konstantinos C Soultanis; Alexandros H Payatakes; Vasilios T Chouliaras; Georgios C Mandellos; Nikolaos E Pyrovolou; Fani M Pliarchopoulou; Panayotis N Soucacos
Journal:  Scoliosis       Date:  2007-10-23

5.  Osteogenesis imperfecta in childhood: effects of spondylodesis on functional ability, ambulation and perceived competence.

Authors:  N Tolboom; E A Cats; P J M Helders; J E H Pruijs; R H H Engelbert
Journal:  Eur Spine J       Date:  2003-11-08       Impact factor: 3.134

6.  Compression Fractures and Partial Phenotype Rescue With a Low Phosphorus Diet in the Chihuahua Zebrafish Osteogenesis Imperfecta Model.

Authors:  Silvia Cotti; Ann Huysseune; Daria Larionova; Wolfgang Koppe; Antonella Forlino; Paul Eckhard Witten
Journal:  Front Endocrinol (Lausanne)       Date:  2022-02-24       Impact factor: 5.555

7.  Association between joint hypermobility, scoliosis, and cranial base anomalies in paediatric Osteogenesis imperfecta patients: a retrospective cross-sectional study.

Authors:  Heidi Arponen; Outi Mäkitie; Janna Waltimo-Sirén
Journal:  BMC Musculoskelet Disord       Date:  2014-12-13       Impact factor: 2.362

Review 8.  Complex spine deformities in young patients with severe osteogenesis imperfecta: current concepts review.

Authors:  R M Castelein; C Hasler; I Helenius; D Ovadia; M Yazici
Journal:  J Child Orthop       Date:  2019-02-01       Impact factor: 1.548

9.  The Managment of cervical spine abnormalities in children with spondyloepiphyseal dysplasia congenita: Observational study.

Authors:  Ali Al Kaissi; Sergey Ryabykh; Olga M Pavlova; Polina Ochirova; Vladimir Kenis; Farid Ben Chehida; Rudolf Ganger; Franz Grill; Susanne Gerit Kircher
Journal:  Medicine (Baltimore)       Date:  2019-01       Impact factor: 1.889

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.